The efficacy of cardiac findings in assessing the outcome in preterms with bronchopulmonary dysplasia

Indian Journal of Pediatrics

Volumn 80, Issue 11, 2013, Pages 896-902

  Akcan, Abdullah Bariş ^a   Kardelen, Firat ^a   Oygucu, Seyhan Erişir ^a   Kocabaş, Abdullah ^a   Özel, Deniz ^a   Akbaş, Halide ^a   Oygür, Nihal ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Newborn; NT proBNP; Tissue doppler echocardiography

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BLOOD LEVEL; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; INFANT; ISOVOLUMETRIC RELAXATION TIME; LUNG DYSPLASIA; M MODE ECHOCARDIOGRAPHY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PEAK TRANSTRICUSPID FILLING VELOCITY IN THE EARLY DIASTOLE; PEAK TRANSTRICUSPID FILLING VELOCITY IN THE EARLY DIASTOLE TRICUSPID VALVE MEDIAL SEGMENT EARLY DIASTOLIC MYOCARDIAL RELAXATION VELOCITY RATIO; PREMATURITY; RELAXATION TIME; RETROSPECTIVE STUDY; RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION; RIGHT VENTRICULAR LATERAL SEGMENT EARLY DIASTOLIC MYOCARDIAL RELAXATION TIME; TISSUE DOPPLER IMAGING; TRICUSPID VALVE LATERAL SEGMENT EARLY DIASTOLIC MYOCARDIAL RELAXATION VELOCITY; TRICUSPID VALVE MEDIAL SEGMENT EARLY DIASTOLIC MYOCARDIAL RELAXATION VELOCITY; BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; ECHOGRAPHY; TREATMENT OUTCOME;

BRONCHOPULMONARY DYSPLASIA; ECHOCARDIOGRAPHY; HUMANS; INFANT; INFANT, PREMATURE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84888337780     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-013-0994-y     Document Type: Article

References (29)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease. N Eng J Med. 1967;276:357-68.
2. Kazzi SNJ, Romero R, McLaughlin K, Ager J, Janisse J. Serial changes in levels of IL-6 and IL-1β in premature infants at risk for bronchopulmonary dysplasia. Pediatr Pulmonol. 2001;31:220-6.
3. Jobe AH, Bancalari E. NICHD/NHLBI/ORD workshop summary: bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723-9.
4. Northway Jr WH, Moss RB, Carlisle KB, et al. Late pulmonary sequale of bronchopulmonary dysplasia. N Engl J Med. 1990;323:1793-9.
5. Farstad T, Brockmeier F, Bratlid D. Cardiopulmonary function in premature infants with bronchopulmonary dysplasia-a 2-year follow-up. Eur J Pediatr. 1995;154:853-8.
6. YIlmaz R, Gencer M, Ceylan E, Demirbag R. Impact of chronic obstructive pulmonary disease with pulmonary hypertansion on both left ventricular systolic and diastolic performance. J Am Soc Echocardiogr. 2005;18:873-81.
7. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-8.
8. Gøtze JP, Kastrup J. Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology. Scand J Clin Lab Invest Suppl. 2001;234:47-51.
9. Maeder M, Amman P, Rickli H, Diethelm M. Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med Wkly. 2003;133:515-8.
10. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr. 2004;93:603-7.
11. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond). 2002;103:75-7.
12. Reynolds EW, Ellington JG, Vranicar M, Bada HS. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics. 2004;114:1297-304.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman AE. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-83.
14. Garcia MJ, Thomas JD, Klein AL. New doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 1998;32:865-75.
15. Waggoner A, Bierig S. Tissue Doppler imaging: A useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J Am Soc Echocardiogr. 2001;14:1143-52.
16. Nir A, Lindinger A, Rauh M, et al. NT-Pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol. 2009;30:3-8.
17. Baraldi E, Fillipone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357:1946-55.
18. Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000;105:1194-201.
19. Trevisanuto D, Milanesi O, Cantarutti F, Zanardo V. Cardiac function in premature infants with bronchopulmonary dysplasia-a 1-year follow up. Eur J Pediatr. 1996;155:622.
20. Korhonen P, Hyödynmaa E, Lautamatti V, Livainen T, Tammela O. Cardiovascular findings in very low birth weight schoolchildren with and without bronchopulmonary dysplasia. Early Hum Dev. 2005;81:497-505.
21. Yates AR, Welty SE, Gest AL, Cua CL. Myocardial tissue Doppler changes in patients with bronchopulmonary dysplasia. J Pediatr. 2008;152:766-70.
22. Gest AL, Bair DK, Vander Straten MC. The effect of outflow pressure upon thoracic duct lymph flow rate in fetal sheep. Pediatr Res. 1992;32:585-8.
23. Gest AL, Bair DK, Vander Straten MC. Thoracic duct lymph flow in fetal sheep with increased venous pressure from electrically induced tachycardia. Biol Neonate. 1993;64:325-30.
24. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 2006;27:861-6.
25. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children and adolescents. Heart. 2003;89:875-8.
26. Yoshibayashi M, Kamiya T, Saito Y, et al. Plasma brain natriuretic concentrations in healthy children from birth to adolescence: Marked and rapid increase after birth. Eur J Endocrinol. 1995;133:207-9.
27. Mir TS, Laux R, Hellweqe HH, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: Marked and rapid increase after birth. Pediatrics. 2003;112:896-9.
28. Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E. N-terminal pro-B-type natriuretic peptide as a marker of bronchoplumonary dysplasia in premature infants. Am J Perinatol. 2010;27:381-6.
29. Maher KO, Reed H, Cuadrado A, et al. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Pediatrics. 2008;121:1484-8.